ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1752

Characterization of Epitopes Identified with Cerebral Vasculature Injury

Melissa Butts1, Jess Edison1, Christopher Tracy1, Brian Stout1, Huazhen Chen2 and Chantal Moratz2, 1Rheumatology, Walter Reed National Military Medical Center, Bethesda, MD, 2Medicine, Uniformed Services University School of Health Sciences, Bethesda, MD

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Antiphospholipid antibodies, Cerebrovascular disease, injury and neuropsychiatric disorders, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Systemic Lupus Erythematosus - Animal Models Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: There is an association between natural antibodies, such as anti-phospholipid antibodies, and vasculature injury in stroke and in SLE models of systemic ischemic damage.   There is also a correlation between chronic inflammatory micro-environments and long term neuro-degeneration.  Preliminary data in our mild traumatic brain injury model demonstrated the development of long term inflammation at the Blood Brain Barrier (BBB) and mild neurocognitive memory defects.  The objective of this study is to determine if the chronic inflammatory microenvironment produced in the BBB in our model, was correlated with increasing preferential association between complement and natural antibodies to mediated vascular damage.   We utilized a long-term longitudinal study to explore this relationship. 

Methods:  Multiple HIFU exposure was used to induce cerebral vascular injury.  Briefly, the animals were anesthetized with 5% Isoflurane and the scalp region was cleared of fur using Nair. Animals assigned to the HIFU-exposure (3 exposures 24 hours apart) experienced a one-millisecond pulse while sham animals did not.  Animals were harvested at a series of time points 2 hours to 30 days post injury. Immunocytochemistry and Immunofluorescence analysis of brain slices was performed to assess vascular integrity and injury.

Results: In the immune competent (C57Bl/6) strain HIFU injury resulted in the activation of the endothelium of the BBB, increased permeability of the BBB to low molecular weight molecules, and deposition of complement C3b, all of which support disruption of endothelial integrity.  In longitudinal studies, a sustained neuro-inflammation was evident 30 days after injury and correlated with neuro-cognitive deficits.   Initial data has demonstrated increased IgG deposition on the luminal surface of the BBB endothelium immediately after injury and at 30 days post injury.  At the 30 day post injury time point there is an increased susceptibility to vascular injury as evidenced by Ferritin deposits within the Virchow-Robin space of the BBB structural unit, specifically in the hippocampus.  At early time points, IgG was associated with complement at the BBB, but epitopes associated with natural antibodies were not dominant.  By 30 days, there was a preferential association between natural antibodies and complement deposition.  Specifically, anti-phospholipid type epitopes were detected.    

Conclusion: Preliminary data suggest that anti-phospholipid type natural antibodies have a stronger association with vascular damage at the 30 day time point than other pathogenic type antibodies. We are currently assessing if the anti-phospholipid antibodies are co-localized with ferritin breaches of the BBB.  Elucidating the mechanics of vascular injury which results in both sustained neuro-pathology and neuro-cognitive decline would provide insight into the emergence and progression in vascular associated neuro-degeneration.  These finding may illuminate a mechanism in Neuropsychiatric Systemic Lupus Erythematous (NPSLE), although there is a correlation of NPSLE with some antibodies, a well-delineated mechanism of how antibody induced cerebral damage occurs has not been defined.  


Disclosure: M. Butts, None; J. Edison, None; C. Tracy, None; B. Stout, None; H. Chen, None; C. Moratz, None.

To cite this abstract in AMA style:

Butts M, Edison J, Tracy C, Stout B, Chen H, Moratz C. Characterization of Epitopes Identified with Cerebral Vasculature Injury [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/characterization-of-epitopes-identified-with-cerebral-vasculature-injury/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-epitopes-identified-with-cerebral-vasculature-injury/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology